Premium Tesamorelin Peptide for Laboratory Research
The Maxoratide Tesamorelin Peptide is a highly purified synthetic analogue of endogenous human Growth Hormone-Releasing Hormone (GHRH). This 44-amino acid compound includes a key structural modification: the addition of a trans-3-hexenoic acid group at the N-terminus. This engineered modification protects the peptide from rapid enzymatic breakdown by dipeptidyl peptidase-4 (DPP-4), significantly extending its half-life and making it a valuable compound in endocrinology, lipolysis, and visceral adipose tissue research.
At Maxoratide, we maintain strict laboratory-grade standards. Each batch of Tesamorelin undergoes rigorous independent testing to confirm sequence accuracy and structural integrity, ensuring researchers receive highly reliable material for in-vitro assays and hormone receptor studies.
Mechanism of Action: Anterior Pituitary GHRH Agonism
In laboratory models, Tesamorelin functions as a selective agonist of growth hormone-releasing hormone (GHRH) receptors located on somatotroph cells in the anterior pituitary gland. Unlike direct secretagogues that bypass physiological regulation, Tesamorelin promotes endogenous growth hormone release in a natural pulsatile pattern while maintaining normal IGF-1 feedback mechanisms.
Key Research Pathways
- Visceral Adipose Tissue Lipolysis: In both in-vitro and clinical research models, Tesamorelin is studied for its ability to enhance lipolysis specifically within visceral fat depots, reducing lipid accumulation in targeted tissues.
- Metabolic Regulation: Research suggests it may influence nutrient partitioning by promoting lipid oxidation and increasing overall energy expenditure rather than fat storage.
- IGF-1 Modulation: It is widely investigated for its ability to elevate baseline IGF-1 levels while maintaining relatively stable glucose and insulin sensitivity profiles compared to other growth-related compounds.
Why Source from Maxoratide?
- Verified Analytical Quality: Every batch is tested using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry to ensure ≥99% purity. COA lab results are available for independent verification.
- US-Based Operations: Orders are shipped directly from our climate-controlled facility in Charlotte, NC, reducing transit delays and avoiding risks associated with international shipping.
- Strict Handling Standards: All compounds are processed under sterile conditions to preserve peptide integrity prior to delivery.
Advanced Reconstitution & Storage Protocols
Due to its complex 44-amino acid structure and N-terminal modification, Tesamorelin requires careful reconstitution to maintain stability. Always use sterile bacteriostatic water as the primary diluent for in-vitro applications.
When adding the diluent, allow it to flow gently down the inner wall of the vial to avoid disrupting the peptide structure. Do not shake or agitate the vial. Instead, gently roll it between your fingers until fully dissolved and optically clear. Foaming may indicate molecular degradation and should be avoided.
Storage Guidelines:
- Before Reconstitution: Store lyophilized powder at -20°C, protected from light
- After Reconstitution: Refrigerate at 4°C and maintain stable conditions
- Avoid repeated freeze-thaw cycles to preserve integrity
Researchers should use appropriate personal protective equipment (PPE), including nitrile gloves, during handling.
Research Disclaimer
Maxoratide Tesamorelin Peptide is intended strictly for in-vitro laboratory research and analytical purposes only. It is not approved for human consumption, diagnostic, or therapeutic use.
